Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | TBXAS1 | P24557 | 8/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | FDPS | P14324 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL868044 | 0.85 | TBXAS1 (0.60) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL11004443 | 0.83 | TBXAS1 (0.61) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL29294048 | 0.83 | ESR1 (0.55) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL724866 | 0.80 | CHRNA7 (0.74) | CHRNA7TDP1L3MBTL1TBXAS1CYP2A6 | |
| SCHEMBL29485692 | 0.80 | CHRNA7 (0.74) | CHRNA7TDP1L3MBTL1TBXAS1CYP2A6 | |
| SCHEMBL27939457 | 0.80 | TBXAS1 (0.64) | CHRNA7TDP1L3MBTL1TBXAS1CYP2A6 | |
| SCHEMBL7165228 | 0.79 | TBXAS1 (0.68) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL9522811 | 0.79 | TDP1 (0.61) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 | |
| Lithium Ion SCHEMBL987070 | 0.79 | TBXAS1 (0.58) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 | |
| Potassium Ion SCHEMBL27486991 | 0.79 | TBXAS1 (0.58) | ESR1CYP19A1CHRNA7TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2001838-A2 | SELECTIVE HYDROXAMATE BASED MMP INHIBITORS | Novartis AG (CH) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007117981-A2 | SELECTIVE HYDROXAMATE BASED MMP INHIBITORS | NOVARTIS AG (CH) | 2007-10-18 | — | — | WO | disclosed |
| EP-1129070-A4 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2005-03-02 | — | — | EP | disclosed |
| EP-1129070-A1 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000027811-A1 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |